MedTrace Logo

Early Intervention Efficacy in COPD

NCT04249310 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6788

Last updated 2022-06-14

Study results available
· View outcomes & findings →

Summary

This study aims to evaluate the time to escalation to triple therapy among the Japanese Chronic obstructive pulmonary disease (COPD) patients newly initiating therapy with a combination of Olodaterol and Tiotropium (herein referred to as Tio/Olo) using real world data.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium/Olodaterol

Soft Mist Inhaler product

DRUG

Tiotropium

Soft Mist Inhaler product

Sponsors & Collaborators

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-27
Primary Completion
2020-08-12
Completion
2020-08-12
FDA Drug
Yes

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04249310 on ClinicalTrials.gov